Veru, Inc. (VERU)
2.80
+0.18
(+6.67%)
USD |
NASDAQ |
Aug 31, 16:00
2.79
-0.01
(-0.36%)
After-Hours: 20:00
Veru Net Income (TTM) : -14.11M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.11M |
| March 31, 2026 | -14.44M |
| December 31, 2025 | -19.20M |
| September 30, 2025 | -15.68M |
| June 30, 2025 | -25.53M |
| March 31, 2025 | -28.55M |
| December 31, 2024 | -29.40M |
| September 30, 2024 | -35.26M |
| June 30, 2024 | -37.57M |
| March 31, 2024 | -33.89M |
| December 31, 2023 | -58.97M |
| September 30, 2023 | -90.02M |
| June 30, 2023 | -120.18M |
| March 31, 2023 | -135.72M |
| December 31, 2022 | -116.10M |
| September 30, 2022 | -83.78M |
| June 30, 2022 | -47.05M |
| March 31, 2022 | -27.55M |
| December 31, 2021 | -16.21M |
| September 30, 2021 | 7.394M |
| June 30, 2021 | -0.1437M |
| March 31, 2021 | -0.4762M |
| December 31, 2020 | 1.559M |
| September 30, 2020 | -18.97M |
| June 30, 2020 | -10.20M |
| Date | Value |
|---|---|
| March 31, 2020 | -9.950M |
| December 31, 2019 | -13.17M |
| September 30, 2019 | -12.02M |
| June 30, 2019 | -16.88M |
| March 31, 2019 | -22.03M |
| December 31, 2018 | -21.83M |
| September 30, 2018 | -23.94M |
| June 30, 2018 | -18.70M |
| March 31, 2018 | -11.56M |
| December 31, 2017 | -9.503M |
| September 30, 2017 | -6.612M |
| June 30, 2017 | -5.684M |
| March 31, 2017 | -4.324M |
| December 31, 2016 | -2.512M |
| September 30, 2016 | 0.3447M |
| June 30, 2016 | 2.798M |
| March 31, 2016 | 3.399M |
| December 31, 2015 | 5.032M |
| September 30, 2015 | 4.346M |
| June 30, 2015 | 3.077M |
| March 31, 2015 | 3.066M |
| December 31, 2014 | 1.773M |
| September 30, 2014 | 2.433M |
| June 30, 2014 | 9.589M |
| March 31, 2014 | 9.157M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 54.20M |
| Johnson & Johnson | 21.04B |
| Eli Lilly & Co. | 26.71B |
| Lexicon Pharmaceuticals, Inc. | -61.12M |